in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Mylan to Buy Remainder of Matrix for $133 Million
9:57 AM MDT | April 3, 2009 | Deepti Ramesh
Mylan (Canonsburg, PA) says it will purchase the stake in Matrix Laboratories (Secunderabad, India) that it does not already own from minority shareholders for about $133 million. Matrix, an active pharmaceutical ingredients and finished dosage forms supplier, will also be delisted from the Indian stock exchanges, Mylan says. The move “will provide Mylan with an opportunity for enhanced flexibility and efficiencies in managing our global technical and commercial operations platform,” says Robert J. Coury, vice chairman and CEO of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee